Cours Arca Biopharma Inc Nasdaq
Actions
US00211Y4070
Recherche biotechnologique et médicale
CA 2022 | - | CA 2023 | - | Capitalisation | 24,5 M 21,85 M |
---|---|---|---|---|---|
Résultat net 2022 | -9 M -8,03 M | Résultat net 2023 | -5 M -4,46 M | VE / CA 2022 | - |
Trésorerie nette 2022 | 42,06 M 37,52 M | Trésorerie nette 2023 | 37,15 M 33,14 M | VE / CA 2023 | - |
PER 2022 |
-3,44
x | PER 2023 |
-4,59
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 98,71% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Thomas Keuer
CEO | Chief Executive Officer | 65 | 01/10/06 |
C. Dekker
DFI | Director of Finance/CFO | 60 | 10/05/21 |
Sharon Perry
LAW | General Counsel | - | 01/01/08 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Anders Hove
BRD | Director/Board Member | 58 | 16/02/17 |
Robert Conway
CHM | Chairman | 70 | 03/09/13 |
Linda Grais
BRD | Director/Board Member | 68 | 01/05/07 |
Varia. 1 janv. | Capi. | |
---|---|---|
+16,73% | 123 Md | |
+13,04% | 107 Md | |
-5,80% | 24,01 Md | |
+1,98% | 22,59 Md | |
-10,09% | 18,16 Md | |
-40,52% | 16,84 Md | |
-14,00% | 16,23 Md | |
+1,18% | 13,43 Md | |
+24,18% | 11,32 Md |